Coya Therapeutics Statistics
Total Valuation
COYA has a market cap or net worth of $114.24 million. The enterprise value is $71.06 million.
| Market Cap | 114.24M |
| Enterprise Value | 71.06M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COYA has 23.46 million shares outstanding. The number of shares has increased by 22.38% in one year.
| Current Share Class | 23.46M |
| Shares Outstanding | 23.46M |
| Shares Change (YoY) | +22.38% |
| Shares Change (QoQ) | +3.59% |
| Owned by Insiders (%) | 5.57% |
| Owned by Institutions (%) | 23.38% |
| Float | 17.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.25 |
| Forward PS | 27.36 |
| PB Ratio | 2.64 |
| P/TBV Ratio | 2.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.86 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.40
| Current Ratio | 13.40 |
| Quick Ratio | 12.29 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.54% and return on invested capital (ROIC) is -36.41%.
| Return on Equity (ROE) | -60.54% |
| Return on Assets (ROA) | -32.27% |
| Return on Invested Capital (ROIC) | -36.41% |
| Return on Capital Employed (ROCE) | -47.61% |
| Weighted Average Cost of Capital (WACC) | 7.57% |
| Revenue Per Employee | $1.00M |
| Profits Per Employee | -$2.71M |
| Employee Count | 8 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, COYA has paid $3,089 in taxes.
| Income Tax | 3,089 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.08% in the last 52 weeks. The beta is 0.60, so COYA's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -25.08% |
| 50-Day Moving Average | 4.88 |
| 200-Day Moving Average | 4.91 |
| Relative Strength Index (RSI) | 53.41 |
| Average Volume (20 Days) | 122,883 |
Short Selling Information
The latest short interest is 1.07 million, so 4.57% of the outstanding shares have been sold short.
| Short Interest | 1.07M |
| Short Previous Month | 1.05M |
| Short % of Shares Out | 4.57% |
| Short % of Float | 6.12% |
| Short Ratio (days to cover) | 4.23 |
Income Statement
In the last 12 months, COYA had revenue of $8.02 million and -$21.67 million in losses. Loss per share was -$1.09.
| Revenue | 8.02M |
| Gross Profit | -8.72M |
| Operating Income | -20.85M |
| Pretax Income | -21.67M |
| Net Income | -21.67M |
| EBITDA | -20.83M |
| EBIT | -20.85M |
| Loss Per Share | -$1.09 |
Balance Sheet
The company has $43.18 million in cash and no debt, with a net cash position of $43.18 million or $1.84 per share.
| Cash & Cash Equivalents | 43.18M |
| Total Debt | n/a |
| Net Cash | 43.18M |
| Net Cash Per Share | $1.84 |
| Equity (Book Value) | 43.28M |
| Book Value Per Share | 1.84 |
| Working Capital | 43.55M |
Cash Flow
| Operating Cash Flow | -15.72M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 19,295 |
| Net Borrowing | n/a |
| Free Cash Flow | -15.72M |
| FCF Per Share | -$0.67 |
Margins
Gross margin is -108.68%, with operating and profit margins of -260.00% and -270.22%.
| Gross Margin | -108.68% |
| Operating Margin | -260.00% |
| Pretax Margin | -270.19% |
| Profit Margin | -270.22% |
| EBITDA Margin | -259.76% |
| EBIT Margin | -260.00% |
| FCF Margin | n/a |
Dividends & Yields
COYA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.38% |
| Shareholder Yield | -22.38% |
| Earnings Yield | -18.97% |
| FCF Yield | -13.76% |
Analyst Forecast
The average price target for COYA is $15.21, which is 212.32% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.21 |
| Price Target Difference | 212.32% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 35.00% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |